|
covid-19 |
38 |
|
youth mental health |
35 |
|
depression |
28 |
|
social unrest |
25 |
|
mental health |
22 |
|
depressive symptoms |
21 |
|
rumination |
21 |
|
epidemiology |
18 |
|
post-traumatic stress disorder |
16 |
|
smartphone overuse |
14 |
|
adolescents |
13 |
|
negative symptoms |
13 |
|
stress |
13 |
|
validation study |
13 |
|
experience sampling method |
12 |
|
momentary positive affect |
12 |
|
pattern glare |
11 |
|
perceptual distortions |
11 |
|
young people |
11 |
|
youth |
11 |
|
anxiety |
10 |
|
delusional disorder |
10 |
|
f-dopa |
10 |
|
first-episode psychosis |
10 |
|
major depressive episode |
10 |
|
positron emission tomography |
10 |
|
psychopathology |
10 |
|
schizophrenia |
10 |
|
striatal dopamine capacity synthesis |
10 |
|
affect |
9 |
|
epidemiological study |
9 |
|
epidemiological youth |
9 |
|
esm |
9 |
|
ideas of reference |
9 |
|
life events |
9 |
|
loneliness |
9 |
|
momentary assessment |
9 |
|
omicron |
9 |
|
physical activity |
9 |
|
psychotic-like experiences |
9 |
|
risk factors |
9 |
|
social context |
9 |
|
traumatic events |
9 |
|
mass screening |
8 |
|
pandemic |
8 |
|
ptsd symptoms |
8 |
|
resilience |
8 |
|
self-discrepancy |
8 |
|
trauma exposure |
8 |
|
big five |
7 |
|
late-onset psychosis |
7 |
|
neurobiology |
7 |
|
neuropsychology |
7 |
|
overcontrolled |
7 |
|
personality |
7 |
|
psychosocial |
7 |
|
ptsd symptoms, women mental health |
7 |
|
resilient |
7 |
|
undercontrolled |
7 |
|
environmental stressors |
6 |
|
family functioning |
6 |
|
stressful life events |
6 |
|
suicidal behaviours |
6 |
|
suicide-related rumination |
6 |
|
anxiety symptoms |
5 |
|
gad-7 |
5 |
|
generalized anxiety disorder |
5 |
|
longitudinal study |
5 |
|
mindful attention |
5 |
|
nightmare |
5 |
|
post-traumatic stress disorder symptoms |
5 |
|
prospective study |
5 |
|
rasch model |
5 |
|
validity |
5 |
|
cognition |
4 |
|
dopamine |
4 |
|
flow model of rumination |
4 |
|
hippocampus |
4 |
|
memory |
4 |
|
psychotic disorders |
4 |
|
relapse |
4 |
|
salience |
4 |
|
technological advances |
4 |
|
treatment response |
4 |
|
clinical decisions |
3 |
|
primary negative symptoms |
3 |
|
depression & mood disorders |
2 |
|
mental illness |
2 |
|
other diagnostic or tool |
2 |
|
prevention strategies |
2 |
|
psychology, pathological |
2 |
|
public health |
2 |
|
screening |
2 |
